NEW YORK, Nov. 5 — A unit of Swedish genomic firm Pyrosequencing and The Cleveland Clinic Foundation announced plans on Monday to co-develop rapid identification and diagnostic tests for mycobacteria. 

This partnership, which was launched to create faster and higher-quality tests for diagnosing and identifying Mycobacterium tuberculosis  and Mycobacterium avium,  is part of Pyrosequencing’s broad plan to enter the molecular diagnostic-testing arena. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.